BackMedicus Sciences Acquisition Overview

Medicus Sciences Acquisition Gross Profit

Medicus Sciences Acquisition's gross profit is $-1.2M, below the sector sector average of $750M.

Get informed when a big investor buys or sells

+ Follow

Quarterly Gross Profit

$-174126.00
↑ 3.46% YoY

As of Sep 30, 2022

Annual Gross Profit (TTM)

$-1172871.00

Trailing 12 months ending Sep 30, 2022

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin

Medicus Sciences Acquisition (MSAC) FAQ

As of the most recent data (September 2022), MSAC shows a gross profit of $-1.2M. That is below the sector sector average of $750M. Scroll down for historical charts and peer comparison views.

The its sector sector average gross profit is about $750M. Medicus Sciences Acquisition is at $-1.2M, which is lower that average. That is roughly 100.2% below the sector mean. Use the comparison chart on this page to see how MSAC stacks up against individual peers as well.

Tracking MSAC's gross profit over time shows whether Medicus Sciences Acquisition is scaling, shrinking, or reshaping that part of the business. The current reading is $-1.2M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this gross profit page, Stockcircle has Medicus Sciences Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect gross profit (currently $-1.2M) with ownership activity and broader fundamentals.